Company intelligence
PercuSense
Intelligent biosensors to power the future of healthcare
Medical Device
Valencia, US
13 employees
3 public signals
About PercuSense
PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment.
Verified activity
Signals from PercuSense
3 published signals
Research & Knowledge
PercuSense conducted a recently started ICU study where a PercuSense continuous metabolic sensor was placed into a patient six hours after an out-of-hospital cardiac arrest.
Reported by PercuSense
Research & Knowledge
PercuSense started its first-in-human ICU study using lactate, tissue oxygen, glucose, and ketone continuously from one probe.
Reported by Brian Kannard
Research & Knowledge
PercuSense is running an ambulatory diabetes study which will be shared soon.
Reported by Brian Kannard